Immunohistochemical study of neuroendocrine differentiation in primary glandular lesions and tumors of the urinary bladder

被引:0
作者
Bollito, ER
Pacchioni, D
Lopez-Beltran, A
Volante, M
Terrone, C
Casetta, G
Mari, M
DePompa, R
Cappia, S
Papotti, M
机构
[1] San Luigi Gonzago Hosp, Div Pathol, Sect Urol Pathol, I-10043 Turin, Italy
[2] San Luigi Gonzago Hosp, Div Urol, I-10043 Turin, Italy
[3] San Giovanni Hosp, Div Pathol, Turin, Italy
[4] San Giovanni Hosp, Div Urol, Turin, Italy
[5] Univ Turin, Dept Clin & Biol Sci, Turin, Italy
[6] Rivoli Hosp, Div Urol, Rivoli, Italy
[7] Univ Cordoba, Reina Sofia Hosp, Div Pathol, Cordoba, Spain
来源
ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY | 2005年 / 27卷 / 04期
关键词
neuroendocrine tumors; bladder neoplasms; immunohistochemistry;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
OBJECTIVE: Neuroendocrine (NE) cells are uncommon in primary adenocarcinoma (AC) and other glandular lesions of the bladder, with no recent study series concerning its significance in differential diagnosis, prognosis or biologic significance. STUDY DESIGN: Sixteen primary bladder AC (enteric-type [n = 71, mucinous [n = 61 and not otherwise specified [NOS] [n = 31), 4 cases of urothelial carcinoma with glandular differentiation, 20 cases of glandular cystitis and 3 urachal remnants with intestinal metaplasia constituted the study series. In addition, 20 specimens of normal-looking urothelium, 15 conventional urothelial carcinomas and 5 small cell carcinoma (SCC) cases were included for comparison. NE differentiation included detection of chromogranin A, neuron-specific enolase (NSE) and synaptophysin by immunohistochemistry. The statistical analysis included the;chi(2) or Fisher exact test. RESULTS: Chromogranin A-positive cells were present in 60% (11 of 16) of primary AC, all of enteric or mucinous type, but not in any of the 3 NOS-type AC investigated. NE differentiation in bladder AC subtypes resulted in highly significant differences between enteric or mucinous vs. NOS type (p = 0.0023). NE differentiation was also different in urachal vs. nonurachal AC (p = 0.020) and primary bladder AC vs. conventional invasive urothelial carcinoma (p < 0.001). Synaptophysin-positive cells were seen in 2 (12.5%) of the 16 primary AC cases, and NSE was negative in the 16 primary bladder AC. All urachal remnants and 70% of glandular cystitis examples had chromogranin A-immunoreactive cells. One of 4 nrothelial carcinomas with glandular differentiation had chromogranin A-immunoreactive cells, but this was not significant when compared with primary AC (p = 0.1). Normal-looking bladder urothelium and conventional urothelial carcinoma specimens had no chromogranin A-immnnoreactive cells. The 5 SCC cases investigated were positive for chromogranin A. No correlation was found between NE differentiation and outcome of primary bladder AC or nrothelial carcinoma with glandular differentiation. CONCLUSION: Primary bladder AC, cystitis glandularis and urachal remnants with intestinal metaplasia showed variable degrees of NE differentiation, with no apparent clinical correlation or prognostic significance. However, the absence of NE differentiation in NOS-type primary bladder AC may help in better defining this uncommon subtype of primary bladder AC.
引用
收藏
页码:218 / 224
页数:7
相关论文
共 28 条
[1]  
ABENOZA P, 1986, ARCH PATHOL LAB MED, V110, P1062
[2]  
Agnese PAD, 2000, SEMIN DIAGN PATHOL, V17, P149
[3]   Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease [J].
Berruti, A ;
Mosca, A ;
Tucci, M ;
Terrone, C ;
Torta, M ;
Tarabuzzi, R ;
Russo, L ;
Cracco, C ;
Bollito, E ;
Scarpa, RM ;
Angeli, A ;
Dogliotti, L .
ENDOCRINE-RELATED CANCER, 2005, 12 (01) :109-117
[4]   Relationship between neuroendocrine features and prognostic parameters in human prostate adenocarcinoma [J].
Bollito, E ;
Berruti, A ;
Bellina, A ;
Mosca, A ;
Leonardo, E ;
Tarabuzzi, R ;
Cappia, S ;
Mari, M ;
Tampellini, M ;
Fontana, D ;
Gubetta, L ;
Angeli, A ;
Dogliotti, L .
ANNALS OF ONCOLOGY, 2001, 12 :S159-S164
[5]  
Capella C, 2000, SEMIN DIAGN PATHOL, V17, P91
[6]   Small cell carcinoma of the urinary bladder - A clinicopathologic analysis of 64 patients [J].
Cheng, L ;
Pan, CX ;
Yang, XMJ ;
Lopez-Beltran, A ;
MacLennan, GT ;
Lin, HQ ;
Kuzel, TM ;
Papavero, V ;
Tretiakova, M ;
Nigro, K ;
Koch, MO ;
Eble, JN .
CANCER, 2004, 101 (05) :957-962
[7]   Intestinal metaplasia is not a strong risk factor for bladder cancer: Study of 53 cases with long-term follow-up [J].
Corica, FA ;
Husmann, DA ;
Churchill, BM ;
Young, RH ;
Pacelli, A ;
LopezBeltran, A ;
Bostwick, DG .
UROLOGY, 1997, 50 (03) :427-431
[8]  
El-Mekresh MM, 1998, BRIT J UROL, V82, P206
[9]  
Garcia Rojo Dario, 1997, Archivos Espanoles de Urologia, V50, P187
[10]  
Hailemariam S, 1998, MODERN PATHOL, V11, P1016